ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Postdoctoral Scientist – Neuroscience (Synuclein Biology) at Eli Lilly and Company - ApplyBlast

Postdoctoral Scientist – Neuroscience (Synuclein Biology)

Eli Lilly and Company

2 months ago

4.0 on Glassdoor

Boston, Massachusetts, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The role involves investigating the molecular and cellular mechanisms driving α‑synuclein dysfunction and aggregation using quantitative biochemistry, engineered cellular systems, and iPSC‑derived neuronal disease models. The scientist will design and execute experiments, develop cellular models, and apply biophysical and imaging assays to build a mechanistic foundation for therapeutic strategies in synucleinopathy.

Responsibilities

Design and execute experiments to uncover α‑synuclein aggregation mechanisms
Develop and characterize cellular and iPSC‑derived neuronal models for synucleinopathy
Lead a research program and communicate findings through publications and presentations

Skills

Qualifications

PhD in cell biology, biochemistry, molecular biology, neuroscience, protein biophysics, or related field

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.